Cited by 251Genomics and Chromatin DynamicsEpigenetics and DNA MethylationChromatin Remodeling and Cancer

Pioneer factors as master regulators of the epigenome and cell fate

Balsalobre, Aurelio, Drouin, Jacques·2022·Nature Reviews Molecular Cell Biology

Abstract

Pioneer factors are transcription factors with the unique ability to initiate opening of closed chromatin. The stability of cell identity relies on robust mechanisms that maintain the epigenome and chromatin accessibility to transcription factors. Pioneer factors counter these mechanisms to implement new cell fates through binding of DNA target sites in closed chromatin and introduction of active-chromatin histone modifications, primarily at enhancers. As master regulators of enhancer activation, pioneers are thus crucial for the implementation of correct cell fate decisions in development, and as such, they hold tremendous potential for therapy through cellular reprogramming. The power of pioneer factors to reshape the epigenome also presents an Achilles heel, as their misexpression has major pathological consequences, such as in cancer. In this Review, we discuss the emerging mechanisms of pioneer factor functions and their roles in cell fate specification, cellular reprogramming and cancer.

Integrity signals

Registry

Crossref · 10.1038/s41580-022-00464-z

Cites

18 of 18 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • The pioneering model of reprogramming has been proposed for OSKM based on their ability to bind to chromatin not normally accessible by transcription factors.

    “The pioneering model of reprogramming has been proposed for OSKM based on their ability to bind to chromatin not normally accessible by transcription factors60–62.”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Balsalobre, A., & Drouin, J.
Affiliations
Montreal Clinical Research Institute (CA)
Corresponding author
Drouin, Jacques
Venue
Nature Reviews Molecular Cell Biology
Published
2022-03-09
Volume
23
Issue
7
Pages
449-464
ISSN
  • 1471-0072 (ISSN-L)
  • 1471-0080
OpenAlex
W4220833476
Cited by
251
References
18
Citations by year
2026: 36 · 2025: 73 · 2024: 64 · 2023: 59 · 2022: 19
FWCI
5.62
Type
journal article
Language
en
Open access
closed
Locations
  • Nature Reviews Molecular Cell Biology (publishedVersion)
  • PubMed (publishedVersion)
Funders
Canadian Institutes of Health Research (154297_1)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Epigenetics and DNA Methylation
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Chromatin Remodeling and Cancer
Keywords
pioneer transcription factors, chromatin accessibility, enhancer activation, histone modifications, cell fate specification, cellular reprogramming, cancer, developmental gene regulation
MeSH terms
Epigenome, Cell Differentiation, Chromatin, Humans, Neoplasms, Transcription Factors

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review